Identification and characterization of novel properties of the human D3 dopamine receptor

被引:30
|
作者
Kuzhikandathil, EV
Westrich, L
Bakhos, S
Pasuit, J
机构
[1] UMDNJ, New Jersey Med Sch, Dept Pharmacol & Physiol, Newark, NJ 07103 USA
[2] UMDNJ, New Jersey Med Sch, Dept Neurosci, Newark, NJ 07103 USA
关键词
D O I
10.1016/j.mcn.2004.01.014
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Among dopamine receptors, the function and properties of the D3 receptor subtype are poorly understood. Here we report the identification and characterization of two unique properties of the human D3 receptor. The D3 receptor exhibits a tolerance property wherein the magnitude of the second agonist-induced response is reduced by 60% compared to the first response and progressively decreases upon repeated agonist application. In addition, unlike the D2 dopamine receptor, the D3 receptor response terminates 15-fold more slowly upon agonist removal. Using D3/D2S chimeric receptors, we demonstrate that D3 receptor tolerance property is mediated by a novel conformational mechanism involving the D3 receptor second cytoplasmic region. The slow response termination rate property requires the third cytoplasmic region and is due to the high affinity of the D3 receptor for ligand as well as its unique G-protein signaling mechanism. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:144 / 155
页数:12
相关论文
共 50 条
  • [41] SLV318, a novel agonist for the dopamine D2 and D3 receptor:: In vitro and in vivo neurochenical characterization
    Hesselink, MB
    van der Neut, M
    Adolfs, T
    Feenstra, R
    Long, S
    van Scharrenburg, G
    MOVEMENT DISORDERS, 2002, 17 : S65 - S65
  • [42] Talipexole variations as novel bitopic dopamine D2 and D3 receptor ligands
    Stank, Lars
    Frank, Annika
    Hagenow, Stefanie
    Stark, Holger
    MEDCHEMCOMM, 2019, 10 (11) : 1926 - 1929
  • [43] Aromatic linker variations in novel dopamine D2 and D3 receptor ligands
    Di Biase, Cristian
    Leitzbach, Luisa
    Frank, Annika
    Zivkovic, Aleksandra
    Stark, Holger
    ARCHIV DER PHARMAZIE, 2024, 357 (08)
  • [44] Is the dopamine D3 receptor mRNA on blood lymphocytes help to for identification and subtyping of schizophrenia?
    M. Urhan-Kucuk
    M. E. Erdal
    M. E. Ozen
    S. Kul
    H. Herken
    Molecular Biology Reports, 2011, 38 : 2569 - 2572
  • [45] Is the dopamine D3 receptor mRNA on blood lymphocytes help to for identification and subtyping of schizophrenia?
    Urhan-Kucuk, M.
    Erdal, M. E.
    Ozen, M. E.
    Kul, S.
    Herken, H.
    MOLECULAR BIOLOGY REPORTS, 2011, 38 (04) : 2569 - 2572
  • [46] Characterization of aripiprazole partial agonist activity at human dopamine D3 receptors
    Tadori, Yoshihiro
    Forbes, Robert A.
    McQuade, Robert. D.
    Kikuchi, Tetsuro
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2008, 597 (1-3) : 27 - 33
  • [47] Dopamine and glutamate dysfunctions in schizophrenia:: Role of the dopamine D3 receptor
    Leriche, L
    Diaz, J
    Sokoloff, P
    NEUROTOXICITY RESEARCH, 2004, 6 (01) : 63 - 71
  • [48] Characterization of aripiprazole partial agonist activity at human dopamine D3 receptors
    Tadori, Y.
    Forbes, A.
    McQuade, R.
    Kikuchi, T.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2008, 18 : S449 - S449
  • [49] Identification and characterization of a novel amphioxus dopamine D1-like receptor
    Burman, Chloe
    Reale, Vincenzina
    Srivastava, Deepak P.
    Evans, Peter D.
    JOURNAL OF NEUROCHEMISTRY, 2009, 111 (01) : 26 - 36
  • [50] Dopamine and glutamate dysfunctions in schizophrenia: Role of the dopamine D3 receptor
    Ludovic Leriche
    Jorge Diaz
    Pierre Sokoloff
    Neurotoxicity Research, 2004, 6 : 63 - 71